Earnings Forecast Research on Perrigo Company (PRGO)

Perrigo Company has received $1.63 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 13 Financial Advisor in the Stock Trading Firms. Among 13 Analysts, Bottom line EPS Estimate for the current quarter is $1.52 while the top line estimate is $1.7 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at -9.44%.

Perrigo Company reported better than expected with a surprise EPS of 3.77% or $0.06 during its most recent quarterly earnings. The Actual EPS was $1.65 compared to the Estimated EPS of $1.59. Dublin based Perrigo Company Last reported the Quarter results on Dec 31, 2016 and the Next earnings date is scheduled to be released on Feb 16, 2017.

Perrigo Company has a Price to Earnings ratio of 10.44 for the trailing twelve month period. The price to book ratio of the company for the most recent quarter is 1.23. For the Most Recent Fiscal Year, Perrigo Company has a price to cash ratio of 7.69. For the Trailing twelve month period, company showed a Net Profit Margin of -26.62% and Return on Equity of the stock is 10.68%.

In the last quarter, Perrigo Company reported Annual Earnings of $1.65. Based on the filings, last years Annual Earnings was, $7.59. In the last Quarter, PRGO reported a surprise Earnings per Share of 3.77% . The consensus estimate for current quarter is $1.63 and for the current fiscal year, the estimate is $6.96. For the Next fiscal year, the estimate is $7.34 based on the consensus.

Perrigo Company (NYSE:PRGO) : On Tuesday heightened volatility was witnessed in Perrigo Company (NYSE:PRGO) which led to swings in the share price. The stock opened for trading at $73.63 and hit $76.2 on the upside , eventually ending the session at $76.15, with a gain of 2.35% or 1.75 points. The heightened volatility saw the trading volume jump to 1,657,463 shares. The 52-week high of the share price is $147.58 and the company has a market cap of $10,918 million. The 52-week low of the share price is at $71.84 .

Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.


Share this post

Leave a Reply